A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
The last time I spoke about Corvus Pharmaceuticals, Inc. (CRVS), it was in a Seeking Alpha article entitled "Corvus Pharmaceuticals: Positive Phase 1 Soquelitinib Trial Data Brings 2025 Catalysts." ...
ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug Authority for the treatment of metastatic non-small cell lung cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results